Treatment outcome and its predictors among children with epilepsy on chronic follow-up in Ethiopia: a systematic review and meta-analysis.
Children
Epilepsy
Ethiopia
Predictors
Treatment outcomes
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
received:
24
07
2024
accepted:
17
10
2024
medline:
31
10
2024
pubmed:
31
10
2024
entrez:
31
10
2024
Statut:
epublish
Résumé
Seventy percent of epileptic patients may not experience seizures if they receive proper treatment with antiepileptic drugs (AEDs). However, many children and adolescents face poor seizure control (PSC). Therefore, the purpose of this review is to systematically and quantitatively summarize the pooled prevalence of PSC and its predictors among children with epilepsy in Ethiopia. The following databases were used to conduct a thorough literature search: Africa Journal of the Online Library, Hinari, Google Scholar, PubMed, Science Direct, EMBASE, Cochrane Database, Sci-Hub, and Scopus. To evaluate the quality of the studies, Newcastle‒Ottawa Scale (NOS) checklists were utilized. The data on study characteristics and prevalence estimates were then combined via random effects meta-analysis, followed by subgroup and sensitivity analyses. Both visual and statistical analyses were employed to assess for any potential publication bias. This review analyzed a total of 12 main studies and reported that the overall prevalence of PSC was 42.42% (95% CI: 33.42-51.42). However, there was significant heterogeneity in the results based on the study region, design, and seizure-free period. The subgroup analysis revealed that the highest prevalence of PSC was found in Southern Nations, Nationalities, and Peoples' (SNNPs) studies (61.88%; 95% CI: 35.91-87.85), studies with a cross-sectional design (46.73%; 95% CI: 36.83-56.62), and studies with a seizure-free period < 6 months (44.69%; 95% CI: 34.51-54.86). However, the lowest prevalence was observed in the Amhara region (35.54%; 95% CI: 27.40-43.67), cohort studies (29.53%; 95% CI: 21.26-38.21), and studies with a seizure-free duration of six months or more (41.64%; 95% CI: 29.94-53.35). The results also revealed a significant correlation between PSC and medication nonadherence (4.64, 95% CI: 2.84-7.58), comorbidities (2.08, 95% CI: 1.01-4.26), and seizure type (3.59, 95% CI: 1.18-10.8). Based on this review, the findings suggest a notable prevalence of poorly controlled seizures (PSC) among children with epilepsy who are receiving antiepileptic drugs (AEDs) in Ethiopian outpatient epilepsy clinics. Seizures of tonic‒clonic status, comorbidities, and medication nonadherence were associated with poor seizure control.
Sections du résumé
BACKGROUND
BACKGROUND
Seventy percent of epileptic patients may not experience seizures if they receive proper treatment with antiepileptic drugs (AEDs). However, many children and adolescents face poor seizure control (PSC). Therefore, the purpose of this review is to systematically and quantitatively summarize the pooled prevalence of PSC and its predictors among children with epilepsy in Ethiopia.
METHODS
METHODS
The following databases were used to conduct a thorough literature search: Africa Journal of the Online Library, Hinari, Google Scholar, PubMed, Science Direct, EMBASE, Cochrane Database, Sci-Hub, and Scopus. To evaluate the quality of the studies, Newcastle‒Ottawa Scale (NOS) checklists were utilized. The data on study characteristics and prevalence estimates were then combined via random effects meta-analysis, followed by subgroup and sensitivity analyses. Both visual and statistical analyses were employed to assess for any potential publication bias.
RESULTS
RESULTS
This review analyzed a total of 12 main studies and reported that the overall prevalence of PSC was 42.42% (95% CI: 33.42-51.42). However, there was significant heterogeneity in the results based on the study region, design, and seizure-free period. The subgroup analysis revealed that the highest prevalence of PSC was found in Southern Nations, Nationalities, and Peoples' (SNNPs) studies (61.88%; 95% CI: 35.91-87.85), studies with a cross-sectional design (46.73%; 95% CI: 36.83-56.62), and studies with a seizure-free period < 6 months (44.69%; 95% CI: 34.51-54.86). However, the lowest prevalence was observed in the Amhara region (35.54%; 95% CI: 27.40-43.67), cohort studies (29.53%; 95% CI: 21.26-38.21), and studies with a seizure-free duration of six months or more (41.64%; 95% CI: 29.94-53.35). The results also revealed a significant correlation between PSC and medication nonadherence (4.64, 95% CI: 2.84-7.58), comorbidities (2.08, 95% CI: 1.01-4.26), and seizure type (3.59, 95% CI: 1.18-10.8).
CONCLUSION
CONCLUSIONS
Based on this review, the findings suggest a notable prevalence of poorly controlled seizures (PSC) among children with epilepsy who are receiving antiepileptic drugs (AEDs) in Ethiopian outpatient epilepsy clinics. Seizures of tonic‒clonic status, comorbidities, and medication nonadherence were associated with poor seizure control.
Identifiants
pubmed: 39478531
doi: 10.1186/s12889-024-20441-9
pii: 10.1186/s12889-024-20441-9
doi:
Substances chimiques
Anticonvulsants
0
Types de publication
Journal Article
Systematic Review
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
3001Informations de copyright
© 2024. The Author(s).
Références
Thijs RD, Surges R, O’Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689–701.
pubmed: 30686584
doi: 10.1016/S0140-6736(18)32596-0
Organization WH. Epilepsy: epidemiology, etiology and prognosis. Fact Sheet. 2001;165.
Epilepsy, GCa. Diseases PfN, Epilepsy IBo, Epilepsy ILa. Atlas: epilepsy care in the world. World Health Organization; 2005.
Organization WH. Epilepsy in the WHO Eastern Mediterranean region: bridging the gap. 2010.
Preux P-M, Druet-Cabanac M. Epidemiology and etiology of epilepsy in sub-saharan Africa. Lancet Neurol. 2005;4(1):21–31.
pubmed: 15620854
doi: 10.1016/S1474-4422(04)00963-9
Giussani G, Cricelli C, Mazzoleni F, Cricelli I, Pasqua A, Pecchioli S, et al. Prevalence and incidence of Epilepsy in Italy based on a Nationwide Database. Neuroepidemiology. 2014;43(3–4):228–32.
pubmed: 25412652
doi: 10.1159/000368801
Kohle F, Madlener M, Bruno EF, Fink GR, Limmroth V, Burghaus L, et al. Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicenter registry. J Neurol. 2022;269(11):5710–9.
pubmed: 35802201
doi: 10.1007/s00415-022-11260-2
Okike CO, Emeagui DO, Ajaegbu OC, Muoneke UV. Outcome of treatment of children with Epilepsy in a Nigerian Tertiary Hospital. Int J Med Health Dev. 2022;27(1):74–80.
doi: 10.4103/ijmh.IJMH_69_20
Tekle-Haimanot R, Abebe M, Forsgren L, Gebre-Mariam A, Heijbel J, Holmgren G, et al. Attitudes of rural people in central Ethiopia toward Epilepsy. Soc Sci Med. 1991;32(2):203–9.
pubmed: 2014416
doi: 10.1016/0277-9536(91)90061-G
Tekle-Haimanot R, Abebe M, Gebre-Mariam A, Forsgren L, Heijbel J, Holmgren G, et al. Community-based study of neurological disorders in rural central Ethiopia. Neuroepidemiology. 1990;9(5):263–77.
pubmed: 2087251
doi: 10.1159/000110783
Leonardi M, Ustun TB. The global burden of epilepsy. Epilepsia. 2002;43:21–5.
pubmed: 12190974
doi: 10.1046/j.1528-1157.43.s.6.11.x
Lewis SA, Noyes J, Hastings RP. Systematic review of epilepsy self-management interventions integrated with a synthesis of children and young people’s views and experiences. J Adv Nurs. 2015;71(3):478–97.
pubmed: 25131643
doi: 10.1111/jan.12511
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on therapeutic strategies. Wiley Online Library; 2010.
Niriayo YL, Mamo A, Kassa TD, Asgedom SW, Atey TM, Gidey K, et al. Treatment outcome and associated factors among patients with epilepsy. Sci Rep. 2018;8(1):17354.
pubmed: 30478263
doi: 10.1038/s41598-018-35906-2
Tefera GM, Woldehaimanot TE, Angamo MT. Poor treatment outcomes and associated factors among epileptic patients at Ambo Hospital, Ethiopia. Gaziantep Med J. 2015;21:9–16.
doi: 10.5455/GMJ-30-163442
Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84(16):1705–13.
pubmed: 25901057
doi: 10.1212/WNL.0000000000001487
Beyene A, Ayalew AF, Mulat G, Simachew Kassa A, Birhan T. The treatment outcomes of epilepsy and its root causes in children attending at the University of Gondar teaching hospital: a retrospective cohort study, 2018. PLoS ONE. 2020;15(3):e0230187.
pubmed: 32163504
doi: 10.1371/journal.pone.0230187
Endayen D, Ayalew M, Getahun M. Multiple anti-seizure medications use and pattern of seizure control in children with epilepsy at neurology follow up clinic, Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. Afr Health Sci. 2023;23(2):732–42.
pubmed: 38223633
doi: 10.4314/ahs.v23i2.84
Gidey K, Chelkeba L, Gemechu TD, Daba FB. Treatment response and predictors in patients with newly diagnosed epilepsy in Ethiopia: a retrospective cohort study. Sci Rep. 2019;9(1):16254.
pubmed: 31700030
doi: 10.1038/s41598-019-52574-y
MekonenTefera G, Woldehaimanot TE, Angamo MT. Poor treatment outcomes and associated factors among epileptic patients at Ambo Hospital, Ethiopia: Etiyopya Ambo Hastanesi’nde epilepsi hastalarında kötü tedavi sonuçları ve ilişkili faktörler. Eur J Ther. 2015;21(1):9–16.
Nasir M, Abebaw E, Ahmed M, Ketema DB. Clinical characteristics, treatment outcome and Associated factors of Epilepsy among Children at hospitals of North–West Ethiopia. Pediatr Health Med Ther. 2023:385–404.
Zewudie A, Mamo Y, Feyissa D, Yimam M, Mekonen G, Abdela A. Epilepsy Treatment Outcome and its predictors among ambulatory patients with Epilepsy at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia. Neurol Res Int. 2020;2020(1):8109858.
pubmed: 32328306
Wazema DH, Assefa ZM, Shiferaw BZ, Geleta OT, Haile TG. Determinants of poor treatment outcome among patients with Epilepsy, who attend Outpatient Epilepsy Clinic at hospitals in Gurage Zone, Ethiopia. Who Attend Outpatient Epilepsy Clinic at Hospitals in Gurage Zone, Ethiopia.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
pubmed: 33782057
doi: 10.1136/bmj.n71
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349.
Dave H, Trivedi NA. Drug utilization pattern of antiepileptic agents among pediatric epilepsy at tertiary care teaching hospital of Gujarat: a cross sectional study. International Journal of Basic & Clinical Pharmacology; 2018.
Ejeliogu EU, Uhunmwangho-Courage A, Yiltok ES, Bok M. Short-term treatment outcome of childhood epilepsy in Jos. Nigeria J Med Tropics. 2020;22:108–14.
doi: 10.4103/jomt.jomt_6_20
Wells GA, Wells G, Shea B, Shea B, O’Connell D, Peterson J, et al. editors. The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses2014.
Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I 2 in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8:1–9.
doi: 10.1186/1471-2288-8-79
Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random‐effects models for meta‐analysis. Res Synthesis Methods. 2010;1(2):97–111.
doi: 10.1002/jrsm.12
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2000.
Alene TD, Engidaye GT, Birhane T, Gedamu S. Epilepsy Treatment Outcome and its predictors among children who had Chronic follow up at Dessie Comprehensive Specialized Hospital. Patient Relat Outcome Measures. 2024:71–80.
Adal HD, Alemu K, Muche EA. Seizure control status and associated factors among pediatric epileptic patients at a neurologic outpatient clinic in Ethiopia. PLoS ONE. 2021;16(11):e0259079.
pubmed: 34731195
pmcid: 8565750
doi: 10.1371/journal.pone.0259079
Abdie O, Tazebew A, Mekonnen Z. Short-term outcome of Convulsive Status Epilepticus in Hospital admitted children: etiology and clinical feature in North–West Ethiopia. Ethiop J Health Biomedical Sci. 2022;12(2).
Hasiso TY, Desse TA. Adherence to treatment and factors affecting adherence of epileptic patients at Yirgalem General Hospital, Southern Ethiopia: a prospective cross-sectional study. PLoS ONE. 2016;11(9):e0163040.
pubmed: 27684491
doi: 10.1371/journal.pone.0163040
Abayneh M, Bacha T, editors OUTCOME OF CHILDREN WITH STATUS EPILEPTICUS IN TIKUR ANBESSA SPECIALIZED HOSPITAL ADDIS ABABA. ETHIOPIA: A 5-YEAR RETROSPECTIVE CROSS-SECTIONAL STUDY2017.
Asnakew G, Tefera E. Pattern of Childhood Epilepsy and Outcome determinants at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiop J Health Biomedical Sci. 2012;5(1):29–35.
Amare HT, Amare AT. Etiology, clinical features, and short-term outcome of seizures in newborns admitted to the University Of Gondar Hospital, Ethiopia. Pediatric health, medicine and therapeutics. 2019:107 – 13.
Gurshaw M, Agalu A, Chanie T. Anti-epileptic drug utilization and treatment outcome among epileptic patients on follow-up in a resource poor setting. J Young Pharm. 2014;6(3):47.
doi: 10.5530/jyp.2014.3.8
Nasir M, Abebaw E, Ahmed M, Ketema DB. Clinical characteristics, treatment outcome and Associated factors of Epilepsy among Children at hospitals of North–West Ethiopia. Pediatr Health Med Ther. 2023;14(null):385–404.
doi: 10.2147/PHMT.S436022
Adal HD, Alemu K, Muche EA. Seizure control status and associated factors among pediatric epileptic patients at a neurologic outpatient clinic in Ethiopia. PLoS ONE. 2021;16.
Organization WH. Epilepsy: a public health imperative. World Health Organization; 2019.
Kariuki SM, Matuja W, Akpalu A, Kakooza-Mwesige A, Chabi M, Wagner RG, et al. Clinical features, proximate causes, and consequences of active convulsive epilepsy in a frica. Epilepsia. 2014;55(1):76–85.
pubmed: 24116877
doi: 10.1111/epi.12392
Meyer A-C, Dua T, Ma J, Saxena S, Birbeck G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ. 2010;88:260–6.
pubmed: 20431789
doi: 10.2471/BLT.09.064147
Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75(3):279–86.
pubmed: 29279892
doi: 10.1001/jamaneurol.2017.3949
Brodie M, Barry S, Bamagous G, Norrie J, Kwan yP. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78(20):1548–54.
pubmed: 22573629
doi: 10.1212/WNL.0b013e3182563b19
Schmidt D. Drug treatment of epilepsy: options and limitations. Epilepsy Behav. 2009;15(1):56–65.
pubmed: 19236951
doi: 10.1016/j.yebeh.2009.02.030
Epilepsy W. A public health imperative. Geneva, Switzerland: WHO; 2019.
Rivera-Castaño L, Sentíes-Madrid H, Berumen-Jaik J, Martínez-Juárez IE. Clinical guideline. Antiepileptic drugs of choice for focal and generalized seizures in adult patients with epilepsy. Revista mexicana de neurociencia. 2019;20(2):25–32.
Nevitt SJ, Sudell M, Cividini S, Marson AG, Smith CT. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Reviews. 2022(4).
Yazie TS, Kefale B, Molla M. Treatment outcome of epileptic patients receiving antiepileptic drugs in Ethiopia: a systematic review and meta-analysis. Behav Neurol. 2021;2021(1):5586041.
pubmed: 34093897
Picot MC, Baldy-Moulinier M, Daurès JP, Dujols P, Crespel A. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population‐based study in a western European country. Epilepsia. 2008;49(7):1230–8.
pubmed: 18363709
doi: 10.1111/j.1528-1167.2008.01579.x
Xue-Ping W, Hai-Jiao W, Li-Na Z, Xu D, Ling L. Risk factors for drug-resistant epilepsy: a systematic review and meta-analysis. Medicine. 2019;98(30):e16402.
pubmed: 31348240
pmcid: 6708813
doi: 10.1097/MD.0000000000016402
Belayneh Z, Mekuriaw B. A systematic review and meta-analysis of anti-epileptic medication nonadherence among people with epilepsy in Ethiopia. Archives Public Health. 2020;78:1–14.
doi: 10.1186/s13690-020-00405-2
Tigistu M, Azale T, Kebebe H, Yihunie T. Frequency of seizure attack and associated factors among patients with epilepsy at University of Gondar Referral Hospital: a cross-sectional study, Gondar, North West Ethiopia, 2017. BMC research notes. 2018;11:1–6.
Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54(3):551–63.
pubmed: 23350722
doi: 10.1111/epi.12074
Bekele F, Gezimu W. Treatment outcome and associated factors among epileptic patients at ambulatory clinic of Mettu Karl Comprehensive Specialized Hospital: a cross-sectional study. SAGE Open Med. 2022;10:20503121221125149.
pubmed: 36172566
doi: 10.1177/20503121221125149
Fadare JO, Sunmonu TA, Bankole IA, Adekeye KA, Abubakar SA. Medication adherence and adverse effect profile of antiepileptic drugs in Nigerian patients with epilepsy. Neurodegenerative Disease Manage. 2018;8(1):25–36.
doi: 10.2217/nmt-2017-0044
Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75(2–3):192–6.
pubmed: 17628429
doi: 10.1016/j.eplepsyres.2007.06.003
Leone MA, Vallalta R, Solari A, Beghi E, Group F. Treatment of first tonic–clonic seizure does not affect mortality: long-term follow-up of a randomized clinical trial. J Neurol Neurosurg Psychiatry. 2011;82(8):924–7.
pubmed: 21531706
doi: 10.1136/jnnp.2010.240069
Jones R, Butler J, Thomas V, Peveler R, Prevett M. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure. 2006;15(7):504–8.
pubmed: 16861012
doi: 10.1016/j.seizure.2006.06.003
Nakhutina L, Gonzalez JS, Margolis SA, Spada A, Grant A. Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav. 2011;22(3):584–6.
pubmed: 21907627
doi: 10.1016/j.yebeh.2011.08.007
Rozensztrauch A, Kołtuniuk A. The quality of life of children with Epilepsy and the impact of the Disease on the Family Functioning. Int J Environ Res Public Health. 2022;19(4):2277.
pubmed: 35206465
doi: 10.3390/ijerph19042277
Lassouw G, Leffers P, De Krom M, Troost J. Epilepsy in a Dutch working population: are employees diagnosed with epilepsy disadvantaged? Seizure. 1997;6(2):95–8.
pubmed: 9153720
doi: 10.1016/S1059-1311(97)80061-1